BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study
BRCA1/2 突变和贝伐单抗在乳腺癌新辅助治疗中的应用:来自 GeparQuinto 研究的三阴性乳腺癌患者的疗效和预后结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2017.77.2285
Fasching, Peter A; Loibl, Sibylle; Hu, Chunling; Hart, Steven N; Shimelis, Hermela; Moore, Raymond; Schem, Christian; Tesch, Hans; Untch, Michael; Hilfrich, Jörn; Rezai, Mahdi; Gerber, Bernd; Costa, Serban Dan; Blohmer, Jens-Uwe; Fehm, Tanja; Huober, Jens; Liedtke, Cornelia; Weinshilboum, Richard M; Wang, Liewei; Ingle, James N; Müller, Volkmar; Nekljudova, Valentina; Weber, Karsten E; Rack, Brigitte; Rübner, Matthias; von Minckwitz, Gunter; Couch, Fergus J